U.S. Drug Price Initiative Faces Scrutiny Amid Claims of Affordability
The U.S. government’s new TrumpRx platform aims to lower prescription drug costs, but experts debate its effectiveness in addressing systemic pricing issues.
Drug Pricing
Read More